Lv2
110 积分 2024-08-08 加入
Chronic cardiovascular-kidney disorder: a new conceptual framework
20天前
已完结
The Novel Nonsteroidal and Selective Mineralocorticoid Receptor Antagonist Finerenone Differentiates from SGLT2 Inhibitor Empagliflozin by Anti-Fibrotic Effects in a Progressive Mouse Kidney Fibrosis Model
3个月前
已关闭
Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome
3个月前
已完结
Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models
4个月前
已完结
HEC95468, a novel soluble guanylate cyclase stimulator, shows protection in the Dahl model of cardiorenal disorder
4个月前
已完结
Quantitative aspects of nitric oxide production in the heart
4个月前
已完结
Nitrite-Nitric Oxide Signaling and Cardioprotection
4个月前
已完结
Cardiorenal Syndrome in Acute Kidney Injury
5个月前
已完结
皖公网安备34019202002308
